Transferrin Level Before Treatment and Genetic Polymorphism in HFE Gene as Predictive Markers for Response to Adalimumab in Crohn’s Disease Patients
Crossref DOI link: https://doi.org/10.1007/s10528-016-9734-0
Published Online: 2016-04-26
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Repnik, Katja
Koder, Silvo
Skok, Pavel
Ferkolj, Ivan
Potočnik, Uroš
Text and Data Mining valid from 2016-04-26